This secondary analysis of 4 randomized clinical trials investigates the association of MDMA with activation of the oxytocin and vasopressin systems, the incidence and severity of MDMA-induced hyponatremia, and the role of fluid restriction in lowering the risk of hyponatremia. This evidence concerns the gene OXT and Hyponatremia.